JPWO2020182635A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020182635A5
JPWO2020182635A5 JP2021552816A JP2021552816A JPWO2020182635A5 JP WO2020182635 A5 JPWO2020182635 A5 JP WO2020182635A5 JP 2021552816 A JP2021552816 A JP 2021552816A JP 2021552816 A JP2021552816 A JP 2021552816A JP WO2020182635 A5 JPWO2020182635 A5 JP WO2020182635A5
Authority
JP
Japan
Prior art keywords
oligomer
formula
immunogenic composition
conjugate
branched
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021552816A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022523570A (ja
JP2022523570A5 (https=
JP7728704B2 (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2020/055950 external-priority patent/WO2020182635A1/en
Publication of JP2022523570A publication Critical patent/JP2022523570A/ja
Publication of JP2022523570A5 publication Critical patent/JP2022523570A5/ja
Publication of JPWO2020182635A5 publication Critical patent/JPWO2020182635A5/ja
Priority to JP2025050172A priority Critical patent/JP2025111445A/ja
Application granted granted Critical
Publication of JP7728704B2 publication Critical patent/JP7728704B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021552816A 2019-03-08 2020-03-06 炭素環誘導体及びそれらのコンジュゲート誘導体、並びにワクチンにおけるそれらの使用 Active JP7728704B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025050172A JP2025111445A (ja) 2019-03-08 2025-03-25 炭素環誘導体及びそれらのコンジュゲート誘導体、並びにワクチンにおけるそれらの使用

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP19161716.6 2019-03-08
EP19161716 2019-03-08
PCT/EP2020/055950 WO2020182635A1 (en) 2019-03-08 2020-03-06 Carbocyclic derivatives and conjugated derivatives thereof, and their use in vaccines

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025050172A Division JP2025111445A (ja) 2019-03-08 2025-03-25 炭素環誘導体及びそれらのコンジュゲート誘導体、並びにワクチンにおけるそれらの使用

Publications (4)

Publication Number Publication Date
JP2022523570A JP2022523570A (ja) 2022-04-25
JP2022523570A5 JP2022523570A5 (https=) 2023-02-28
JPWO2020182635A5 true JPWO2020182635A5 (https=) 2023-02-28
JP7728704B2 JP7728704B2 (ja) 2025-08-25

Family

ID=66000932

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021552816A Active JP7728704B2 (ja) 2019-03-08 2020-03-06 炭素環誘導体及びそれらのコンジュゲート誘導体、並びにワクチンにおけるそれらの使用
JP2025050172A Pending JP2025111445A (ja) 2019-03-08 2025-03-25 炭素環誘導体及びそれらのコンジュゲート誘導体、並びにワクチンにおけるそれらの使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025050172A Pending JP2025111445A (ja) 2019-03-08 2025-03-25 炭素環誘導体及びそれらのコンジュゲート誘導体、並びにワクチンにおけるそれらの使用

Country Status (8)

Country Link
US (1) US20220152183A1 (https=)
EP (1) EP3934696A1 (https=)
JP (2) JP7728704B2 (https=)
CN (1) CN114126662A (https=)
BR (1) BR112021017239A2 (https=)
CA (1) CA3131741A1 (https=)
MX (1) MX2021010555A (https=)
WO (1) WO2020182635A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB202115151D0 (en) 2021-10-21 2021-12-08 Glaxosmithkline Biologicals Sa Methods

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0115176D0 (en) * 2001-06-20 2001-08-15 Chiron Spa Capular polysaccharide solubilisation and combination vaccines
GB0220198D0 (en) * 2002-08-30 2002-10-09 Chiron Spa Modified saccharides,conjugates thereof and their manufacture
ES2461350T3 (es) 2003-01-30 2014-05-19 Novartis Ag Vacunas inyectables contra múltiples serogrupos de meningococos
GB0409750D0 (en) * 2004-04-30 2004-06-09 Chiron Srl Integration of meningococcal conjugate vaccination
JP6786394B2 (ja) 2014-02-28 2020-11-18 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム 改変髄膜炎菌ｆＨｂｐポリペプチド
GB202013262D0 (en) * 2020-08-25 2020-10-07 Glaxosmithkline Biologicals Sa Vaccine Composition

Similar Documents

Publication Publication Date Title
US7862823B1 (en) Multivalent vaccine composition with mixed carrier
CA2647455C (en) Processes for the conjugation of poly n-acetylated glucosamine to a carrier protein
RU2412944C2 (ru) Иммуногены для вакцин против менингита а
JP2020533438A5 (https=)
HRP20160685T1 (hr) Pripravci koji sadrže pneumokokne antigene
CA2435681A1 (en) Multivalent meningococcal polysaccharide-protein conjugate vaccine
JP2005504718A5 (https=)
JP2020533442A5 (https=)
WO2020131763A3 (en) Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof
JPH11506491A (ja) 修飾したメニンゴコッカスのポリサッカライドを結合したワクチン
JP2025111445A5 (https=)
JPWO2021019102A5 (https=)
AU2017234319B2 (en) Novel polysaccharide-protein conjugates and process to obtain thereof
JP2005511662A5 (https=)
RU2008145859A (ru) Вакцина против никотиновой зависимости
JPWO2020182635A5 (https=)
WO2021244996A1 (en) Synthetic oligosaccharide vaccines against streptococcus pneumoniae with microparticle adjuvant formulations
JP6091214B2 (ja) ポリ−グリセロールリン酸をベースにした抗グラム陽性細菌ワクチン
WO1997041888A1 (fr) Complexe immunogene, son utilisation, son procede de preparation et vaccin le contenant
US20030068324A1 (en) Conjugate vaccine composed of the polysaccharide moiety of the lipopolysaccharide of Vibrio cholerae O139 bound to tetanus toxoid
JP2013510882A5 (https=)
Naso et al. Polysaccharide conjugate vaccines for the prevention of gram-positive bacterial infections
MXPA99010289A (es) Composición de vacuna multivalente con portador mixto
JP2025541816A (ja) Ｋｌｅｂｓｉｅｌｌａ ｐｎｅｕｍｏｎｉａｅに対するワクチン
RU2024133739A (ru) Компонент поливалентной пневмококковой полисахаридной конъюгированной вакцины и его применение